DHT and Hair Loss: What Every Woman Needs to Know

If you have been researching why your hair is thinning, you have probably encountered the term DHT. It comes up in ingredient lists, in product claims, in dermatology articles — but rarely with a clear explanation of what it actually is, why it matters specifically for women, and what you can realistically do about it without a prescription.

This is that explanation.

What Is DHT?

DHT stands for dihydrotestosterone. It is an androgen — a hormone in the same family as testosterone — and it is produced when the enzyme 5-alpha-reductase converts testosterone into a more potent form. DHT has roughly two to five times the binding affinity for androgen receptors compared to testosterone, and it is approximately ten times more potent in its androgenic effects.

DHT is present in both men and women. In women, the amounts are significantly lower — but the hair follicle's sensitivity to DHT is what determines whether hair loss occurs, not the absolute level of the hormone. A woman with average DHT levels but highly androgen-sensitive follicles can experience significant thinning. This is why hair loss driven by DHT is called androgenetic alopecia — it involves both androgens and genetic predisposition.

According to the NIH's StatPearls database, androgenetic alopecia impacts approximately 50% of both men and women, making it the most common hair loss disorder in the world.

How DHT Causes Hair Loss: The Follicular Miniaturization Process

DHT does not cause hair to fall out in the way a fever or sudden shock might trigger shedding. Its mechanism is slower and more insidious — a process called follicular miniaturization.

Here is what happens step by step:

• DHT binds to androgen receptors in susceptible follicles. Not all follicles are equally sensitive. Those at the crown and top of the scalp tend to carry more androgen receptors and respond more strongly to DHT — which is why female pattern hair loss concentrates in these areas.
• The growth phase shortens. DHT signals the follicle to exit the active growth phase (anagen) earlier than it should. Over successive cycles, the anagen phase becomes progressively shorter — producing shorter, thinner strands with each cycle.
• The follicle physically shrinks. The dermal papilla — the cluster of cells at the base of the follicle that controls growth — receives suppressive signals from DHT. Over time, the follicle miniaturizes: terminal hairs (thick, pigmented, visible) gradually transform into vellus hairs (fine, colorless, barely visible). This is why thinning hair often appears fine and transparent rather than visibly absent.
• Growth factors are suppressed. DHT upregulates a gene called DKK-1, which inhibits the Wnt/β-catenin signaling pathway — a key driver of hair follicle regeneration. It also reduces expression of IGF-1, bFGF, and VEGF, the growth factors that support the follicle during the anagen phase.

The result is a gradual, progressive reduction in hair density that develops over years. Because each cycle produces slightly finer hair, the change is often noticed only after significant miniaturization has already occurred.

Why DHT-Related Hair Loss Is Different in Women

Male pattern hair loss follows a well-known progression — receding temples, thinning crown, eventual baldness. Female androgenetic alopecia presents very differently:

• Diffuse thinning across the top and crown of the scalp rather than distinct bald patches
• A widening of the part line — often the first visible sign
• The frontal hairline is usually preserved, unlike in men
• Overall reduction in volume and density rather than complete loss in any one area
• Hair that feels finer in texture and breaks more easily

Because the pattern is diffuse rather than patterned, female androgenetic alopecia is frequently misattributed to stress, nutritional deficiency, or general aging — and the DHT component goes unaddressed. The earlier the hormonal driver is identified, the more effective intervention becomes.

When Does DHT-Related Hair Loss Start in Women?

DHT-driven thinning in women can begin at any point after puberty, but there are three hormonal windows when it most commonly accelerates:

• Post-pill hair loss: When oral contraceptives — which suppress androgen activity — are discontinued, androgen levels rebound. Women with androgen-sensitive follicles may notice significant shedding in the months following.
• Postpartum: Estrogen surges during pregnancy keep hair in the growth phase. After delivery, estrogen drops sharply, and the relative androgen dominance that follows can trigger shedding and accelerate DHT sensitivity in genetically predisposed women.
• Perimenopause and menopause: As estrogen and progesterone decline, their protective inhibition of 5-alpha-reductase weakens. Progesterone in particular acts as a natural 5-alpha-reductase inhibitor — when its levels fall, DHT conversion at the follicle increases. This is the most common and most sustained window of DHT-related hair loss in women.

The Two-Enzyme Problem: Type I and Type II 5-Alpha-Reductase

5-alpha-reductase exists in two forms that are relevant to hair loss. Type II is the isoform most directly associated with androgenetic alopecia and is concentrated in the hair follicle's dermal papilla. Type I is distributed across sebaceous glands and keratinocytes in the scalp.

Pharmaceutical DHT blockers like finasteride primarily target Type II. Saw palmetto's fatty acids — including β-sitosterol — inhibit both isoforms. Research indicates saw palmetto achieves approximately 32% inhibition of Type I and 38% inhibition of Type II 5-alpha-reductase at therapeutic doses. This broad-spectrum inhibition across both isoforms is one reason saw palmetto is particularly relevant as a topical botanical DHT inhibitor for the scalp environment.

What the Research Says About Botanical DHT Inhibition

The most studied botanical 5-alpha-reductase inhibitor is saw palmetto (Serenoa repens). The clinical evidence has strengthened considerably in recent years:

• A 2020 systematic review in Skin Appendage Disorders analyzed five randomized controlled trials and two prospective cohort studies. Across studies, 60% of participants reported improvement in overall hair quality and 83.3% demonstrated increased hair density on investigator assessment.
• A 2023 randomized, double-blind, placebo-controlled trial (Sudeep et al., published in Clinical, Cosmetic and Investigational Dermatology, doi: 10.2147/CCID.S435795) enrolled 80 adults with mild-to-moderate androgenetic alopecia. Over 16 weeks, saw palmetto produced a marked reduction in serum DHT levels versus placebo (p<0.001), reduced hair fall by 29%, and increased hair density by 5.17%.
• A 180-day randomized, double-blind, placebo-controlled study (PMC12881706) using a proprietary saw palmetto fatty acid extract demonstrated significant improvements in terminal hair count in both anterior and posterior scalp regions versus placebo in men and women with self-perceived hair thinning.
• A 2025 PMC review on botanical preparations for hair loss in women (PMC12689892) confirmed that saw palmetto inhibits 5-alpha-reductase to reduce DHT by approximately 30–40% — noting this as the most clinically substantiated botanical DHT inhibitor currently available.

For context: finasteride inhibits approximately 70% of 5-alpha-reductase activity and dutasteride approximately 98%. Saw palmetto's 30–40% inhibition is more modest — but it carries none of the side effect profile associated with pharmaceutical inhibitors, and as a topical application it delivers that inhibition directly at the follicle level, where it matters most.

How Botanical Green Lab Addresses DHT at the Scalp

The most effective approach to DHT-related hair loss combines two mechanisms: blocking DHT production at the follicle level and improving scalp circulation to support follicles that DHT has already begun to miniaturize. Botanical Green Lab's pre-shampoo treatments are built around exactly this dual approach.

Applied to dry hair before shampooing, the oil-based formulas penetrate to the scalp before water exposure compromises absorption — delivering active botanicals directly to the follicular environment where DHT activity occurs.

• Scalp Detoxifying — Cayenne & Saw Palmetto: The most direct DHT-targeting formula in the range. Saw palmetto inhibits 5-alpha-reductase at the follicle; capsaicin from cayenne drives vasodilation and increased blood flow, delivering nutrients to follicles that DHT has begun to miniaturize. Best for pattern-related thinning at the crown or part line, and for buildup-prone scalps where follicle congestion compounds the DHT effect.
• Scalp Energizing — Ginger & Saw Palmetto: Saw palmetto's DHT inhibition combined with ginger's anti-inflammatory gingerols, which address the chronic low-grade scalp inflammation that DHT-related miniaturization triggers. Best for scalps that have progressively lost density over time and show signs of follicular fatigue.
• Scalp Soothing — Lemongrass & Rosemary: Rosemary's carnosic acid supports microcirculation and antioxidant defense at the follicle level. A 2015 randomized controlled trial (PubMed ID: 25842469) found rosemary oil matched minoxidil 2% for hair count at six months in androgenetic alopecia patients. Best for sensitive scalps experiencing diffuse DHT-related shedding.
• Scalp Balancing — Clove Leaf & Moringa: Clove's eugenol has documented 5-alpha-reductase inhibiting properties alongside sebum-regulating and anti-inflammatory benefits. DHT stimulates sebaceous gland activity — excess sebum around the follicle opening compounds miniaturization. This formula addresses both the hormonal and sebum components simultaneously.
• Sensitive Scalp — Lavender & Cypress: For scalps too reactive for stronger warming actives. A 2016 study (PubMed ID: 27123160) found topical lavender oil produced significantly increased follicle number and depth, performing comparably to minoxidil in the same model. Best for women with androgen-sensitive but easily irritated scalps.
• Silver Hair Shine — Blue Tansy & Almond: Blue tansy carries DHT-inhibiting properties and is formulated specifically for postmenopausal scalps managing both density loss and the transition to grey or silver hair. The most targeted option for women in the post-menopause phase of androgenetic alopecia progression.
• Scalp Revitalizing — Coconut & Coffee Bean: Caffeine has been shown to directly penetrate the hair follicle and counteract the growth-suppressing effect of androgens on follicle cells in vitro. The dual green and black coffee bean caffeine complex provides intensive follicular stimulation for scalps where miniaturization has already produced significant volume loss.

For an oil-free option: The Capsaicin+ 15 Min Hair Follicle Serum combines dual capsaicin for circulation, caffeine for follicular stimulation, niacinamide for scalp inflammation, and a complete B-vitamin complex — all in a water-based formula. Apply to dry scalp, leave 15 minutes, shampoo as normal. Ideal for fine or oily hair types.

Not sure which formula fits your scalp? The Pre-Shampoo Scalp Care Sample Set lets you try multiple treatments before committing to a full size.

What to Realistically Expect

DHT-related hair loss develops over years. Addressing it takes consistent effort over months. Here is an honest timeline for a weekly pre-shampoo botanical routine:

• Weeks 1–4: Reduced shedding during washing and brushing as the scalp environment stabilizes and follicles receive more consistent nourishment.
• Weeks 4–8: Noticeable reduction in daily hair fall. The scalp feels less reactive or less congested depending on your baseline.
• Months 2–3: Fine new hairs becoming visible at the part line and hairline as follicles stimulated back into anagen produce new growth.
• Months 3–6: Measurable improvement in density and strand thickness as the full hair cycle completes and healthier follicles replace miniaturized ones.

Botanical DHT inhibition is not as potent as pharmaceutical intervention — but it also carries none of the risks. And for many women, particularly those in the early to moderate stages of androgenetic alopecia, consistent topical application of proven botanical 5-alpha-reductase inhibitors produces meaningful, sustained results.

Other Factors That Amplify DHT Sensitivity

DHT sensitivity is partly genetic, but several factors can amplify its effect on follicles:

• Scalp inflammation: Chronic inflammation around the follicle upregulates androgen receptor expression, making follicles more responsive to DHT even at the same hormone levels.
• Insulin resistance: Higher insulin levels stimulate androgen production and increase 5-alpha-reductase activity. This is why PCOS — which involves insulin resistance — is frequently associated with androgenetic alopecia in younger women.
• Scalp buildup: Sebum and product buildup around the follicle opening can trap DHT in the follicular canal, prolonging its contact with androgen receptors. Regular pre-shampoo scalp detoxification addresses this directly.
• Stress: Elevated cortisol increases androgen production systemically and accelerates the shift of follicles from anagen into telogen — compounding the DHT effect.

The Bottom Line

DHT is the primary hormonal driver of the most common form of hair loss in women. It works slowly, progressively, and at the follicle level — which is precisely why topical botanical intervention, applied consistently before shampooing, is the most rational approach to addressing it. Getting active DHT-inhibiting botanicals to the scalp before the wash cycle removes them is what makes the difference between a routine that manages the problem and one that doesn't.

The follicle does not die in androgenetic alopecia — it miniaturizes and waits. The right botanical stimulus, applied consistently, can support it back toward active growth.

Explore the full Botanical Green Lab Scalp Treatment Collection — 100% vegan, sulfate-free, and manufactured in Fountain Valley, California since 2010.